FROM PREVENTION TO PRECISION: IS BIOTECH THE ANSWER?

In a lively discussion, experts explore the transformative potential of biotechnology in healthcare, emphasizing the shift from treatment to prevention and precision medicine. They highlight the challenges and opportunities in Europe, such as fragmented markets and the need for unified financial systems, while acknowledging the continent's rich talent pool. The conversation also touches on the economic implications of drug pricing and the importance of investing in prevention as a cost-effective strategy. The role of artificial intelligence in accelerating drug development and the potential for Europe to become a hub for biotech innovation are also discussed. The dialogue underscores the need for strategic investments and regulatory adjustments to foster growth in the biotech sector.